ANXA1 and head and neck squamous cell carcinoma: MiR-196b has been demonstrated to promote cell proliferation and invasion, and to suppress apoptosis by targeting SOCS2 [176] and PCDH-17 [177] in LSCC cells and ANXA1 in HNSCC cells [178].